Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127182771 | 12718277 | 1 | I | 20160901 | 20160906 | 20160906 | EXP | GB-FRESENIUS KABI-FK201606052 | FRESENIUS KABI | 84.00 | YR | F | Y | 0.00000 | 20160906 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127182771 | 12718277 | 1 | PS | FUROSEMIDE (MANUFACTURER UNKNOWN) | FUROSEMIDE | 1 | Oral | U | UNKNOWN | 18902 | 20 | MG | TABLET | QD | |||||
| 127182771 | 12718277 | 2 | SS | FUROSEMIDE (MANUFACTURER UNKNOWN) | FUROSEMIDE | 1 | U | UNKNOWN | 18902 | ||||||||||
| 127182771 | 12718277 | 3 | SS | FUROSEMIDE (MANUFACTURER UNKNOWN) | FUROSEMIDE | 1 | U | UNKNOWN | 18902 | ||||||||||
| 127182771 | 12718277 | 4 | SS | AMITRIPTYLINE | AMITRIPTYLINE | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 127182771 | 12718277 | 5 | C | ADALAT CC | NIFEDIPINE | 1 | Unknown | 0 | 20 | MG | BID | ||||||||
| 127182771 | 12718277 | 6 | C | ALENDRONIC ACID | ALENDRONIC ACID | 1 | Unknown | 0 | 70 | MG | /wk | ||||||||
| 127182771 | 12718277 | 7 | C | CALCICHEW | CALCIUM CARBONATE | 1 | Unknown | 0 | BID | ||||||||||
| 127182771 | 12718277 | 8 | C | CARBOMER | CARBOMER | 1 | Unknown | 0 | |||||||||||
| 127182771 | 12718277 | 9 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Unknown | 0 | 15 | MG | QD | ||||||||
| 127182771 | 12718277 | 10 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Unknown | 0 | 500 | MG | |||||||||
| 127182771 | 12718277 | 11 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | 0 | 10 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127182771 | 12718277 | 1 | Joint swelling |
| 127182771 | 12718277 | 2 | Blood pressure measurement |
| 127182771 | 12718277 | 3 | Gravitational oedema |
| 127182771 | 12718277 | 4 | Depression |
| 127182771 | 12718277 | 5 | Product used for unknown indication |
| 127182771 | 12718277 | 6 | Product used for unknown indication |
| 127182771 | 12718277 | 7 | Product used for unknown indication |
| 127182771 | 12718277 | 8 | Product used for unknown indication |
| 127182771 | 12718277 | 9 | Product used for unknown indication |
| 127182771 | 12718277 | 10 | Product used for unknown indication |
| 127182771 | 12718277 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127182771 | 12718277 | OT |
| 127182771 | 12718277 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127182771 | 12718277 | Dizziness | |
| 127182771 | 12718277 | Drug interaction | |
| 127182771 | 12718277 | Fall | |
| 127182771 | 12718277 | Haemorrhagic stroke | |
| 127182771 | 12718277 | Hypotension | |
| 127182771 | 12718277 | Loss of consciousness | |
| 127182771 | 12718277 | Orthostatic hypotension | |
| 127182771 | 12718277 | Syncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127182771 | 12718277 | 1 | 20150710 | 0 | ||
| 127182771 | 12718277 | 5 | 20150708 | 0 |